Search research articles
Contact Us
Filters
Showing results (551-560 of 706) with videos related to
Page
of 71
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2006
Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma
Roger J Packer, Amar Gajjar, Gilbert Vezina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2013
Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study
Amar Gajjar, Clinton F Stewart, David W Ellison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2012
Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study
Regina I Jakacki, Peter C Burger, Tianni Zhou, et al.
Neuro-Oncology
|
September 29, 2012
Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma--a Pediatric Brain Tumor Consortium study
Sridharan Gururangan, Jason Fangusaro, Tina Young Poussaint, et al.
Journal of Medicinal Chemistry
|
July 31, 2019
Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based Drug Design of a Mcl-1 Inhibitor (AZD5991) and Other Synthetic Macrocycles
Amber Y S Balazs, Rodrigo J Carbajo, Nichola L Davies, et al.
Journal of Medicinal Chemistry
|
March 1, 2021
Correction to "Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based Drug Design of a Mcl-1 Inhibitor (AZD5991) and Other Synthetic Macrocycles"
Amber Y S Balazs, Rodrigo J Carbajo, Nichola L Davies, et al.
Journal of Medicinal Chemistry
|
October 24, 2012
Novel acidic 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor with reduced acyl glucuronide liability: the discovery of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid (AZD8329)
James S Scott, Joanne deSchoolmeester, Elaine Kilgour, et al.
JCO Precision Oncology
|
July 8, 2024
Midline Low-Grade Gliomas of Early Childhood: Focus on Targeted Therapies
Ludmila Papusha, Margarita Zaytseva, Agnesa Panferova, et al.
Oncotarget
|
May 20, 2015
The emerging role of NG2 in pediatric diffuse intrinsic pontine glioma
Sridevi Yadavilli, Joseph Scafidi, Oren J Becher, et al.
Journal of the National Cancer Institute
|
June 19, 2009
Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study
Gregory T Armstrong, Qi Liu, Yutaka Yasui, et al.
Page
of 71
Search research articles
Search
Showing results (551-560 of 706) with videos related to
Sort By:
Page
of 71
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2006
Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma
Roger J Packer, Amar Gajjar, Gilbert Vezina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2013
Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study
Amar Gajjar, Clinton F Stewart, David W Ellison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2012
Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study
Regina I Jakacki, Peter C Burger, Tianni Zhou, et al.
Neuro-Oncology
|
September 29, 2012
Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma--a Pediatric Brain Tumor Consortium study
Sridharan Gururangan, Jason Fangusaro, Tina Young Poussaint, et al.
Journal of Medicinal Chemistry
|
July 31, 2019
Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based Drug Design of a Mcl-1 Inhibitor (AZD5991) and Other Synthetic Macrocycles
Amber Y S Balazs, Rodrigo J Carbajo, Nichola L Davies, et al.
Journal of Medicinal Chemistry
|
March 1, 2021
Correction to "Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based Drug Design of a Mcl-1 Inhibitor (AZD5991) and Other Synthetic Macrocycles"
Amber Y S Balazs, Rodrigo J Carbajo, Nichola L Davies, et al.
Journal of Medicinal Chemistry
|
October 24, 2012
Novel acidic 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor with reduced acyl glucuronide liability: the discovery of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid (AZD8329)
James S Scott, Joanne deSchoolmeester, Elaine Kilgour, et al.
JCO Precision Oncology
|
July 8, 2024
Midline Low-Grade Gliomas of Early Childhood: Focus on Targeted Therapies
Ludmila Papusha, Margarita Zaytseva, Agnesa Panferova, et al.
Oncotarget
|
May 20, 2015
The emerging role of NG2 in pediatric diffuse intrinsic pontine glioma
Sridevi Yadavilli, Joseph Scafidi, Oren J Becher, et al.
Journal of the National Cancer Institute
|
June 19, 2009
Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study
Gregory T Armstrong, Qi Liu, Yutaka Yasui, et al.
Page
of 71